| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2140746 | Lung Cancer | 2015 | 7 Pages |
Abstract
In this study we found no significant differences in overall survival in propensity matched patients diagnosed with stage I NSCLC treated either surgically or with SABR. After 3 years there seems to be a trend toward improved survival in patients who were treated surgically.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sahar Mokhles, Naomi Verstegen, Alex P.W.M. Maat, Ãzcan Birim, Ad J.J.C. Bogers, M. Mostafa Mokhles, Frank J. Lagerwaard, Suresh Senan, Johanna J.M. Takkenberg,